Modelling a way out of yellow fever

Affiliations

¹ Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, Netherlands. Electronic address: l.g.visser@lumc.nl.
² Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, Netherlands.

Comment

Leo G Visser et al. Lancet. 2016.

. 2016 Dec 10;388(10062):2847-2848.

doi: 10.1016/S0140-6736(16)31330-7. Epub 2016 Nov 10.

¹ Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, Netherlands. Electronic address: l.g.visser@lumc.nl.
² Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, Netherlands.

No abstract available

Comment on

Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial.
Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG. Roukens AH, et al. PLoS One. 2008 Apr 23;3(4):e1993. doi: 10.1371/journal.pone.0001993. PLoS One. 2008. PMID: 18431480 Free PMC article. Clinical Trial.
17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.
Martins RM, Maia Mde L, Farias RH, Camacho LA, Freire MS, Galler R, Yamamura AM, Almeida LF, Lima SM, Nogueira RM, Sá GR, Hokama DA, de Carvalho R, Freire RA, Pereira Filho E, Leal Mda L, Homma A. Martins RM, et al. Hum Vaccin Immunother. 2013 Apr;9(4):879-88. doi: 10.4161/hv.22982. Epub 2013 Jan 30. Hum Vaccin Immunother. 2013. PMID: 23364472 Free PMC article. Clinical Trial.
Fractional dosing of yellow fever vaccine to extend supply: a modelling study.
Wu JT, Peak CM, Leung GM, Lipsitch M. Wu JT, et al. Lancet. 2016 Dec 10;388(10062):2904-2911. doi: 10.1016/S0140-6736(16)31838-4. Epub 2016 Nov 10. Lancet. 2016. PMID: 27837923 Free PMC article.